|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-08-25 EDT
|
5-day change | 1st Jan Change | ||
| 0.1820 SEK | +2.82% |
|
-5.21% | -35.92% |
| 06-01 | Flerie portfolio company Xintela reports positive study results for stem cell product | FW |
| 06-01 | Xintela Presents Positive Results from Clinical Study with Its Stem Cell Product XSTEM | CI |
Chart: Technical Analysis
Stock exchange
Nasdaq Stockholm
XINT 0.1820 kr
+2.82%
88.6K
kr
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq Stockholm
| XINT | 0.1820SEK | +2.82% | 88.6K kr | |
Deutsche Boerse AG
| 1XT | 0.003800EUR | -20.83% | 0 € |
- Stock Market
- Stocks
- XINT Stock
- Charts Xintela AB
Select your edition
All financial news and data tailored to specific country editions
